Life Sciences News | BioTuesdays by Kilmer Lucas IR

Developments

NIH awards grant to Marker Therapeutics through SBIR program

Marker Therapeutics (NASDAQ:MRKR) has announced that it has been awarded a $2 million grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to support the clinical...

August 12, 2024

Developments

OneMedNet successfully integrates its proprietary AI technology into its data curation process, boosting efficiency up to 5X

OneMedNet (NASDAQ:ONMD) reported today that it has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise de-identification of patient data. This innovation...

August 9, 2024

Developments

Awakn screens first patient in Phase 3 trial of treatment for AUD

Awakn Life Sciences (CSE:AWKN; OTCQB:AWKNF; FSE:954) has announced that the first patient has been screened in its landmark MORE-KARE Phase 3 trial of AWKN-001, an investigational, novel medication-assisted treatment...

August 9, 2024

Developments

Veru meets full enrollment target in Phase 2b study of Enobosarm for Obesity

Veru (NASDAQ:VERU) announced that it has reached its targeted full enrollment of 150 patients for its Phase 2b QUALITY clinical trial of enobosarm, in combination with semaglutide, aimed at muscle preservation for high...

August 8, 2024

Developments

Rockwell launches ergonomic hemodialysis packaging solution for home patients and acute facilities

Rockwell Medical (NASDAQ:RMTI) announced the launch of a convenience pack including pre-mixed containers of the company’s hemodialysis concentrate products, offering in-home dialysis patients and acute dialysis...

August 8, 2024

Developments

89bio names Francis Sarena as COO

89Bio (NASDAQ:ETNB) announced the appointment of Francis Sarena as chief operating officer, effective August 5, 2024. Mr. Sarena brings 25 years of biotech industry experience to his new role at 89bio. Prior to joining...

August 7, 2024

Developments

Silo partners with global CRO for preclinical study to advance homing peptide in MS

Silo Pharma (NASDAQ:SILO) has entered into an agreement with WuXi AppTec for a preclinical small animal study of SPU-16, a central nervous system (CNS) homing peptide targeting multiple sclerosis (MS). Silo Pharma is...

August 7, 2024

Developments

Quoin Pharma plans clinical study of peeling skin syndrome in children

Quoin Pharmaceuticals (NASDAQ:QNRX) announced plans to initiate an investigator-led clinical study to evaluate the safety and efficacy of QRX003 in pediatric patients with peeling skin syndrome (PSS). The study will be...

August 6, 2024

Developments

Abivax achieves key enrollment milestone in Phase 3 trial of Obefazimod in UC

Abivax SA (Euronext Paris, NASDAQ:ABVX) reports reaching the 600-patient enrollment milestone for its Phase 3 ABTECT trial to evaluate its lead investigational drug candidate, Obefazimod, in patients with moderate-to...

August 6, 2024

Executive Moves

Carisma Therapeutics expands SAB with renowned KOLs

Carisma Therapeutics (NASDAQ:CARM) has appointed Drs. Scott Friedman and Ira Tabas to its scientific advisory board (SAB). “It is an honor to welcome Dr. Friedman and Dr. Tabas to our SAB,” said Steven...

August 6, 2024

Markets

EF Hutton starts CytoSorbents at buy; PT $10

EF Hutton launched coverage of CytoSorbents (NASDAQ:CTSO) with a “buy” rating and $10 target price. The stock closed at $1.03 on July 26. CytoSorbents’ innovative filter cartridges, CytoSorb, and DrugSorb, stand...

July 29, 2024

Developments

BioResorative’s Chief Scientist named section editor of top-tier Journal of Translational Medicine

BioRestorative Therapies (NASDAQ:BTRX) announced that Francisco Silva, the company’s chief scientist and vice president of research and development, has been appointed section editor of the newly launched Regenerative...

July 23, 2024

NIH awards grant to Marker Therapeutics through SBIR program

OneMedNet successfully integrates its proprietary AI technology into its data curation process, boosting efficiency up to 5X

Awakn screens first patient in Phase 3 trial of treatment for AUD

Veru meets full enrollment target in Phase 2b study of Enobosarm for Obesity

Rockwell launches ergonomic hemodialysis packaging solution for home patients and acute facilities

89bio names Francis Sarena as COO

Silo partners with global CRO for preclinical study to advance homing peptide in MS

Quoin Pharma plans clinical study of peeling skin syndrome in children

Abivax achieves key enrollment milestone in Phase 3 trial of Obefazimod in UC

Carisma Therapeutics expands SAB with renowned KOLs

EF Hutton starts CytoSorbents at buy; PT $10

BioResorative’s Chief Scientist named section editor of top-tier Journal of Translational Medicine

General

More